Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Clinical trial matching software Market to reach USD 379.39 million by the end of 2029.

Global Clinical trial matching software Market Size study & Forecast, by Deployment Type (Web & Cloud Based, On-premise), End Use (Pharmaceutical & Biotechnology Companies, CROs, Medical Device Firms), by Distribution Channel (Supermarkets/Hypermarkets, Online Stores, Convenience Stores, Others), and Regional Analysis, 2022-2029

Product Code: HLSHIT-38542892
Publish Date: 10-01-2023
Page: 200

Global Clinical trial matching software Market is valued approximately USD 137.29 million in 2021 and is anticipated to grow with a healthy growth rate of more than 14.05% over the forecast period 2022-2029. Clinical trial matching software help patients and their proxies (e.g., caregivers and providers) enroll in clinical trials by identifying potential trials and, in some cases, providing additional support services such as educational materials or personnel who can answer questions or assist patients. Factors such as Surge in number of clinical trials globally, Growing prevalence of infectious and chronic diseases, increase in the outsourcing of clinical research are driving the growth of market.

Various diseases such as tuberculosis, HIV, cancer ,cardiovascular and others require new ways of medications and treatment which result in the growth of clinical trials . According to the World Health Organization , in 2019 around 1.4 million people lost their lives due to Tuberculosis, out of these, 208,000 deaths resulted in people who were HIV positive. Further, in 2020 the number of deaths from TB increased to 1.5 million, out of which around 214 000 people were also diagnosed by HIV. Clinical trials play important role in discovering new ways for detection, diagnosis, and treatment of various diseases. It includes chronic diseases such as cancer, neurological diseases, and others Clinical trials are also helpful in identifying probable side effects of any new treatment or medication. For instance, according to registry of clinical trials ClinicalTrials.gov – during April 2020, the registered COVID-19 studies worldwide were estimated at just 260 trials and as of March 2021, the number of studies increased to 4,992 trials. Moreover, Rising digitization in healthcare sector and Increasing R& D Funding activities in Clinical Research are few other factors creating new opportunities for the market growth over the forecast period. However, high deployment & maintenance costs associated with Clinical Trials Matching Solutions are the major factors impeding the market growth over the forecast period of 2022-2029.

The key regions considered for the Global Clinical trial matching software Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share owing to the ongoing clinical trials activities, high number of clinical trials activities along with the presence of a significant number of manufacturers in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate over the forecast period 2022-2029 growing healthcare expenditure in the region, increase in number of clinical trials which is increasing the demand for the software. Along with this, high government support for the clinical trials development is also driving the growth for the region over the forecasted period.

Major market player included in this report are:
Dacima Software Inc
IBM Clinical development
Antidote Technologies, Inc.
Clinical Trials Mobile Application
SSS International Clinical Research
Advarra
Aris Global
MasterControl, Inc.
DZS Clinical Services
Yprime LLC

Recent Developments in the Market:
 In December 2021, Leading European clinical research company Optimapharm acquired SSS International. The organization was able to expand its portfolio of clinical research studies due to this acquisition.
 In July 2022 CT-SCOUTTM is now expanding its technology offering into a third therapeutic area Dermatology. CT-SCOUTTM is now available in three dermatological indications includes atopic dermatitis, Psoriasis, and hidradenitis suppurativa. The company’s multi-device platform that allows health care professionals to identify trial candidates precisely.

Global Clinical trial matching software Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Deployment Type, End Use and Distribution Channel, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Deployment Type:
Web & Cloud Based
On-premise
By End Use:
Pharmaceutical & Biotechnology Companies
CROs
Medical device firm
By Distribution Channel:
Supermarkets/Hypermarkets
Online Stores
Convenience Stores
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
1.2.1. Clinical Trial Matching Software Market, by region, 2019-2029 (USD Million)
1.2.2. Clinical Trial Matching Software Market, by Deployment Type, 2019-2029 (USD Million)
1.2.3. Clinical Trial Matching Software Market, by End Use, 2019-2029 (USD Million)
1.2.4. Clinical Trial Matching Software Market, by Distribution Channel, 2019-2029 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Clinical Trial Matching Software Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Clinical Trial Matching Software Market Dynamics
3.1. Clinical Trial Matching Software Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Surge in number of clinical trials globally
3.1.1.2. Growing prevalence of infectious and chronic diseases
3.1.1.3. Increase in the outsourcing of clinical research
3.1.2. Market Challenges
3.1.2.1. High deployment & maintenance costs associated with Clinical Trials Matching Solutions.
3.1.3. Market Opportunities
3.1.3.1. Rising digitization in healthcare sector
3.1.3.2. Increasing R&D activities by market players
Chapter 4. Global Clinical Trial Matching Software Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Clinical Trial Matching Software Market, by Deployment Type
6.1. Market Snapshot
6.2. Global Clinical Trial Matching Software Market by Deployment Type, Performance – Potential Analysis
6.3. Global Clinical Trial Matching Software Market Estimates & Forecasts by Deployment Type 2019-2029 (USD Million)
6.4. Clinical Trial Matching Software Market, Sub Segment Analysis
6.4.1. Web & Cloud Based
6.4.2. On-premise
Chapter 7. Global Clinical Trial Matching Software Market, by End Use
7.1. Market Snapshot
7.2. Global Clinical Trial Matching Software Market by End Use, Performance – Potential Analysis
7.3. Global Clinical Trial Matching Software Market Estimates & Forecasts by End Use 2019-2029 (USD Million)
7.4. Clinical Trial Matching Software Market, Sub Segment Analysis
7.4.1. Pharmaceutical & Biotechnology Companies
7.4.2. CROs
7.4.3. Medical device firm
Chapter 8. Global Clinical Trial Matching Software Market, by Distribution Channel
8.1. Market Snapshot
8.2. Global Clinical Trial Matching Software Market by Distribution Channel, Performance – Potential Analysis
8.3. Global Clinical Trial Matching Software Market Estimates & Forecasts by Distribution Channel 2019-2029 (USD Million)
8.4. Clinical Trial Matching Software Market, Sub Segment Analysis
8.4.1. Supermarkets/Hypermarkets
8.4.2. Online Stores
8.4.3. Convenience Stores
8.4.4. Others
Chapter 9. Global Clinical Trial Matching Software Market, Regional Analysis
9.1. Clinical Trial Matching Software Market, Regional Market Snapshot
9.2. North America Clinical Trial Matching Software Market
9.2.1. U.S. Clinical Trial Matching Software Market
9.2.1.1. Deployment Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. End Use breakdown estimates & forecasts, 2019-2029
9.2.1.3. Distribution Channel breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Clinical Trial Matching Software Market
9.3. Europe Clinical Trial Matching Software Market Snapshot
9.3.1. U.K. Clinical Trial Matching Software Market
9.3.2. Germany Clinical Trial Matching Software Market
9.3.3. France Clinical Trial Matching Software Market
9.3.4. Spain Clinical Trial Matching Software Market
9.3.5. Italy Clinical Trial Matching Software Market
9.3.6. Rest of Europe Clinical Trial Matching Software Market
9.4. Asia-Pacific Clinical Trial Matching Software Market Snapshot
9.4.1. China Clinical Trial Matching Software Market
9.4.2. India Clinical Trial Matching Software Market
9.4.3. Japan Clinical Trial Matching Software Market
9.4.4. Australia Clinical Trial Matching Software Market
9.4.5. South Korea Clinical Trial Matching Software Market
9.4.6. Rest of Asia Pacific Clinical Trial Matching Software Market
9.5. Latin America Clinical Trial Matching Software Market Snapshot
9.5.1. Brazil Clinical Trial Matching Software Market
9.5.2. Mexico Clinical Trial Matching Software Market
9.6. Rest of The World Clinical Trial Matching Software Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Dacima Software Inc
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. IBM Clinical development
10.2.3. Antidote Technologies, Inc.
10.2.4. Clinical Trials Mobile Application
10.2.5. SSS International Clinical Research
10.2.6. Advarra
10.2.7. Aris Global
10.2.8. MasterControl, Inc.
10.2.9. DZS Clinical Services
10.2.10. Yprime LLC
10.2.11. Dacima Software Inc Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now